| |
| |
|
| Insider
Information: |
Ryan Jason |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
188,356 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3,866,949 |
|
|
| Total
Shares |
188,356 |
|
|
| Total
Value |
$3,866,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 1,187.0%
|
358.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
Chief Financial Officer |
2018-07-31 |
0 |
2014-04-16 |
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2024-01-11 |
0 |
2024-01-11 |
188,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-11-02 |
4 |
AS |
$50.00 |
$486,550 |
D/D |
(9,731) |
52,601 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-05 |
4 |
S |
$61.26 |
$1,330,935 |
D/D |
(21,726) |
52,601 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-05 |
4 |
OE |
$0.08 |
$133,302 |
D/D |
21,726 |
71,289 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-01-02 |
4 |
S |
$64.00 |
$149,504 |
D/D |
(2,336) |
50,265 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-01-16 |
4 |
AS |
$64.38 |
$1,354,233 |
D/D |
(21,035) |
49,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-01-16 |
4 |
OE |
$29.63 |
$592,600 |
D/D |
20,000 |
69,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
AS |
$67.53 |
$1,012,950 |
D/D |
(15,000) |
49,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
OE |
$29.63 |
$444,450 |
D/D |
15,000 |
64,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-15 |
4 |
AS |
$78.26 |
$1,173,900 |
D/D |
(15,000) |
49,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-15 |
4 |
OE |
$29.63 |
$444,450 |
D/D |
15,000 |
57,083 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-01 |
4 |
A |
$78.75 |
$1,018,395 |
D/D |
12,932 |
62,162 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
AS |
$74.87 |
$467,959 |
D/D |
(6,139) |
56,023 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-03 |
4 |
S |
$72.40 |
$72 |
D/D |
(1) |
56,022 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-16 |
4 |
AS |
$74.30 |
$256,261 |
D/D |
(3,449) |
52,573 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$465,054 |
D/D |
(3,403) |
49,170 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$5,783,455 |
D/D |
(42,215) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$952,835 |
D/D |
(6,955) |
42,215 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,278 |
17,114 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-10-17 |
4 |
S |
$0.86 |
$1,101 |
D/D |
(1,281) |
15,833 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-12-31 |
4 |
S |
$0.26 |
$19,310 |
D/D |
(73,732) |
189,626 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
247,525 |
263,358 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
129 |
5,876 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-10-17 |
4 |
S |
$3.19 |
$134 |
D/D |
(42) |
5,834 |
0 |
% |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-11-16 |
4 |
B |
$1.27 |
$72,187 |
I/I |
56,742 |
56,742 |
2.66 |
% |
|
78 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
